WAU
JAZZ icon

Wellington-Altus USA’s Jazz Pharmaceuticals JAZZ Stock Holding History

Wellington-Altus USA’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.9K Hold
269
– – 0.04% 298
2026
Q1 		$64.8K Buy
269
+49
+22% +$8.56K 0.04% 302
2025
Q4 		$37.4K Buy
+220
New +$33.7K 0.03% 349

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Wellington-Altus USA's JAZZ Position: Q2 2026 in Review

Wellington-Altus USA held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 269 shares worth $50.9K. The position accounts for 0.04% of the portfolio, ranked #298.

Wellington-Altus USA first reported a position in JAZZ in Q4 2025 and has held it in 3 quarters since. The position peaked at $64.8K in Q1 2026. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Wellington-Altus USA held 269 shares of Jazz Pharmaceuticals worth $50.9K as of Q2 2026.
  • Wellington-Altus USA left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
  • Jazz Pharmaceuticals made up 0.04% of Wellington-Altus USA's portfolio in Q2 2026, its #298 holding.
  • Wellington-Altus USA first reported a position in Jazz Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Wellington-Altus USA's Jazz Pharmaceuticals position peaked at $64.8K in Q1 2026.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Wellington-Altus USA's 13F filing for Q2 2026, filed 17 Sep 2026.